A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris

NCT04883736 EARLY_PHASE1 COMPLETED

To demonstrate the therapeutic equivalence and safety of Tretinoin Gel Microsphere, 0.1% (Taro Pharmaceuticals U.S.A, Inc.) and RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1% (Valeant) in the treatment of acne vulgaris.

Details

Lead sponsor	Sun Pharmaceutical Industries, Inc.
Phase	EARLY_PHASE1
Status	COMPLETED
Enrolment	973
Start date	Mon Aug 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Apr 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Acne Vulgaris

Interventions

• Tretinoin Gel Microsphere, 0.1%
• RETIN-A MICRO® (Tretinoin) Gel Microsphere, 0.1%
• Placebo Control

Countries

United States